文献速递主动脉疾病

锥形束CT在标准与复杂EVAR技术评估中的前瞻性非随机研究

Prospective nonrandomized study to evaluate cone beam computed tomography for technical assessment of standard and complex endovascular aortic repair.
PubMed 文献 · J Vasc Surg · 2019-10-11

该前瞻性非随机研究纳入154例患者共170例主动脉手术,评估锥形束CT(CBCT)在标准与复杂腔内动脉瘤修复(EVAR)技术评估中的效用。结果显示CBCT检测内漏率(53%)显著高于DSA(14%)和CTA(46%),并在28%患者中发现阳性发现,其中18%促使术中或延迟干预;仅用DSA会遗漏79%的阳性发现。

要点

  • CBCT检测内漏率53%,显著高于DSA的14%和CTA的46%。
  • CBCT在28%患者中发现阳性发现,18%促使干预,F-BEVAR中阳性发现率更高(35% vs 16%)。
  • 仅用DSA会遗漏79%的阳性发现,包括49%需二次干预的患者。

核心结论

  • CBCT可可靠检测阳性发现,近五分之一患者因此立即修订手术,F-BEVAR患者中比例最高。
  • CBCT检测任何内漏的比例高于DSA或CTA,但多数内漏仅被观察。
  • 仅用DSA无法检测需要修订的阳性发现。

研究设计与样本

  • 前瞻性数据库录入2016至2017年连续接受标准或复杂EVAR的患者,回顾性分析。
  • 共154例患者(126例男性;平均年龄74±8岁),170例主动脉手术,包括85例开窗分支EVAR(F-BEVAR)、42例腹主动脉及胸主动脉EVAR、32例髂分支装置EVAR和11例主动脉相关干预。
  • 技术评估使用CBCT(含或不含对比增强)、数字减影血管造影(DSA)和CT血管造影(CTA);慢性肾脏病3B或4期患者使用不含对比增强的CBCT。

主要发现

  • F-BEVAR的辐射暴露和碘对比剂用量显著高于其他主动脉手术(174±101 Gy∙cm2 vs 1135±113 Gy∙cm2,144±60 mL vs 122±49 mL,P < .05)。
  • 主动脉手术的平均有效剂量(ED)为74±36 mSv,透视18±18 mSv,DSA采集7±7 mSv,CBCT 15±7 mSv,CTA成像34±17 mSv(P < .001)。
  • CBCT检测内漏率53%,显著高于DSA的14%和CTA的46%(P < .001)。
  • CBCT在43例患者(28%)中识别52项阳性发现,F-BEVAR高于其他主动脉手术(35% vs 16%;P = .01)。
  • 阳性发现包括支架压缩或扭结29例(17%)、I型或III型内漏16例(10%)、动脉夹层或血栓7例(5%);28例(18%)阳性发现促使术中(17%)或延迟干预(1%),另15例(10%)轻微阳性发现仅观察无临床后果。

临床怎么用

  • CBCT可用于标准与复杂EVAR的术中技术评估,尤其F-BEVAR患者阳性发现率更高。
  • CBCT检测内漏敏感性高于DSA和CTA,但多数内漏仅需观察。
  • 仅依赖DSA可能遗漏需干预的阳性发现,CBCT可辅助术中决策。
  • 用CBCT替代DSA和CTA可减少碘对比剂用量和辐射有效剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to analyze the utility of cone beam computed tomography (CBCT) for technical assessment of standard and complex endovascular aneurysm repair (EVAR). METHODS: Data of consecutive patients who underwent standard or complex EVAR in 2016 and 2017 at our institution were entered into a prospective database and analyzed retrospectively. There were 154 patients (126 male; mean age, 74 ± 8 years) enrolled in a prospective study between 2016 and 2017. A total of 170 aortic procedures were investigated, including 85 fenestrated-branched EVARs (F-BEVARs), 42 abdominal and thoracic EVARs, 32 EVARs with iliac branch devices, and 11 aorta-related interventions. Technical assessment was done using CBCT with and without contrast enhancement, digital subtraction angiography (DSA), and computed tomography angiography (CTA). Patients with stage 3B or stage 4 chronic kidney disease had CBCT without contrast enhancement. Radiation exposure (mean dose-area product), effective dose (ED), and amount of iodine contrast agent were analyzed. End points were presence of any endoleak, positive findings warranting possible intervention (stent kink or compression, type I or type III endoleak, dissection, thrombus), and need for secondary intervention. RESULTS: Radiation exposure and amount of iodine contrast agent were significantly higher (P < .05) for F-BEVAR compared with other aortic procedures (174±101 Gy∙cm2 vs 1135±113 Gy∙cm2 and 144±60 mL vs 122±49 mL). ED averaged 74±36 mSv for the aortic procedure, 18 ± 18 mSv for fluoroscopy, 7 ± 7 mSv for DSA acquisition, 15±7 mSv for CBCT, and 34±17 mSv for CTA imaging (P < .001). Endoleak detection was significantly higher (P < .001) with CBCT (53%) compared with DSA (14%) and CTA (46%). CBCT identified 52 positive findings in 43 patients (28%), higher for F-BEVAR compared with other aortic procedures (35% vs 16%; P = .01). Positive findings included stent compression or kink in 29 patients (17%), type I or type III endoleak in 16 patients (10%), and arterial dissection or thrombus in 7 patients (5%). Of these, 28 patients (18%) had positive findings that prompted an intraoperative (17%) or delayed intervention (1%). Another 15 patients (10%) with minor positive findings were observed with no clinical consequence. DSA alone would not have detected positive findings in 34 of 43 patients (79%), including 21 patients (49%) who needed secondary interventions. CTA diagnosed two (1%) additional endoleaks requiring intervention (one type IC, one type IIIC) that were not diagnosed by CBCT. Replacing DSA and CTA by CBCT would have resulted in 53% ± 13% reduction in amount of iodine contrast agent and 55% ± 12% reduction in ED (P < .05). CONCLUSIONS: CBCT reliably detected positive findings prompting immediate revisions in nearly one of five patients, with the highest rates among F-BEVAR patients. Detection of any endoleak was higher with CBCT compared with DSA or CTA, but most endoleaks were observed. DSA alone failed to detect positive findings warranting revisions.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Tenorio ER, Oderich GS, Sandri GA, et al. Prospective nonrandomized study to evaluate cone beam computed tomography for technical assessment of standard and complex endovascular aortic repair. J Vasc Surg. 2019. PMID: 31611108. doi:10.1016/j.jvs.2019.07.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。